Sinovac Biotech, Ltd.
SVA Other · Other · CN
Sinovac Biotech, Ltd. (NASDAQ: SVA) is a leading biopharmaceutical company headquartered in Beijing, China. Established in 2001, Sinovac specializes in the research, development, manufacturing, and commercialization of vaccines that protect against infectious diseases.
| Reported | FY2022 | FY2023 | FY2024 | FY2025 | TTM | |
|---|---|---|---|---|---|---|
| Revenue | $1.5B | $470.2M | $361.4M | $386.0M | $10.0B | |
| EPS | $1.00 | −$0.19 | $1.27 | −$0.83 | $30.07 | |
| Free cash flow | −$1.2B | −$17.5M | −$154.3M | −$560.9M | −$786.4M | |
| Net debt | −$11.3B | −$10.8B | −$9.8B | −$6.1B | −$5.8B |